MAL2 and breast cancer: The results showed that the down-regulation of N-cadherin and Vimentin induced by MAL2 silencing were partially reversed (Fig. 7C), indicating that stabilizing the β-catenin could partially rescue the inhibitory effect of MAL2 downregulation on migration, invasion and EMT progression of BC cells.